Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men.

Sigurdardottir, Vilborg; Fagerberg, Björn; Wikstrand, John; Schmidt, Caroline; Hulthe, Johannes (2007). Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men. Atherosclerosis, 190(1), pp. 187-193. Elsevier 10.1016/j.atherosclerosis.2006.01.016

[img] Text
Atherosclerosis 2007_Sigurdardottir.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (139kB) | Request a copy

OBJECTIVES

The aim of the study was to test the hypothesis that circulating markers of inflammation (high-sensitive C-reactive protein, hsCRP) and oxidative modification of lipids (oxidized low-density lipoprotein, oxLDL) were associated with the occurrence of echolucent rather than echogenic femoral artery plaques in a cross-sectional population based cohort of 513, 61-year-old men.

BACKGROUND

The relationships between circulating oxLDL, hsCRP and the occurrence of echolucent plaques in the femoral artery have not previously been investigated.

METHODS

The levels of circulating oxLDL and hsCRP were determined in plasma by ELISA. Plaque occurrence, size and echogenicity were measured by B-mode ultrasound in the right femoral artery. Assessment of plaque echogenicity was based on the classification (grades 1-4) proposed by Gray-Weale et al.

RESULTS

A higher frequency of echolucent femoral plaques was observed in subjects with the metabolic syndrome and current smokers (p=0.01 and p<0.001, respectively) as well as with increasing levels of oxLDL and hsCRP (p=0.002 and p=0.005, respectively). In a multiple logistic regression analysis oxLDL and current smokers turned out to be independent associated with the presence of echolucent femoral artery plaques.

CONCLUSIONS

The results of the present study support our hypothesis that circulating oxLDL is a marker of an unstable echolucent plaque phenotype in the femoral artery in man.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Sigurdardottir, Vilborg

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0021-9150

Publisher:

Elsevier

Language:

English

Submitter:

Vilborg Sigurdardottir

Date Deposited:

07 Mar 2016 08:54

Last Modified:

05 Dec 2022 14:51

Publisher DOI:

10.1016/j.atherosclerosis.2006.01.016

PubMed ID:

16494881

BORIS DOI:

10.7892/boris.76016

URI:

https://boris.unibe.ch/id/eprint/76016

Actions (login required)

Edit item Edit item
Provide Feedback